Premium
Evaluating the impact of metabolic syndrome on postoperative thyroidectomy outcomes
Author(s) -
Elsamna Samer T.,
Suri Pooja,
Mir Ghayoour S.,
Roden Dylan F.,
Paskhover Boris
Publication year - 2021
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.26588
Subject(s) - medicine , metabolic syndrome , thyroidectomy , complication , logistic regression , odds ratio , diabetes mellitus , endocrine system , obesity , surgery , thyroid , endocrinology , hormone
Objective Metabolic syndrome (MetS) has previously been linked to increased risk of postoperative morbidity and mortality in other surgical undertakings. Because MetS is a consequence of endocrine dysfunction, and given the thyroid's crucial role in endocrine homeostasis, we sought to evaluate the association between MetS and postoperative outcomes of thyroidectomy. Methods Data were acquired from the ACS‐NSQIP database from years 2005 to 2017. Patients with obesity, diabetes, and hypertension were defined as having MetS. Odds ratios (OR) were obtained for outcomes to quantify risk with multivariate logistic regression. Results Outcomes significantly affected by MetS included overall complication (OR: 2.00), extended postoperative stay (OR: 1.52), medical complication (OR: 1.48), surgical complication (OR: 1.62), and mortality (OR: 2.33). Conclusions Patients with MetS undergoing thyroidectomy are at increased risk of an increased length of stay, overall complications, and mortality.